EXKIVITY (Mobocertinib) 40 Mg Capsule

Exkivity (Mobocertinib) is a prescription medicine used to treat a specific type of non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) exon 20 insertion. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Exkivity (Mobocertinib) is a prescription medicine used to treat a specific type of non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) exon 20 insertion. Exkivity belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of certain proteins that promote the growth of cancer cells.

What is Exkivity (Mobocertinib) ?

Exkivity (Mobocertinib) is a prescription medicine used to treat a specific type of non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) exon 20 insertion. Exkivity belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of certain proteins that promote the growth of cancer cells.

How to buy Exkivity (Mobocertinib) in India?

Exkivity (Mobocertinib) suppliers in India: Alleviare India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specializing in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of the latest medicines that are available in countries of Europe and USA.

The order for Exkivity (Mobocertinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

What are the indications and usage ?

Exkivity (Mobocertinib) is indicated for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations, as detected by an FDA-approved test, who have received prior platinum-based chemotherapy.

What are the facts of Exkivity (Mobocertinib) 40 Mg Capsule ?

Medicine Name: Exkivity

Generic Name: Mobocertinib

Approval Date: May 28, 2021

Company Name: Takeda Pharmaceutical Company Limited

Exkivity (Mobocertinib) is available.

Get In Touch

Exkivity (Mobocertinib) suppliers in India

ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Exkivity (Mobocertinib) on prescription and Import License in Patient’s Name only.

For foreign countries patients, Exkivity (Mobocertinib) can be made available in Send your inquiry to find Exkivity (Mobocertinib) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Exkivity (Mobocertinib)

For Exkivity (Mobocertinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details